: Aeglea BioTherapeutics started at buy with 90-cent stock price target at Stifel

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Generated by Feedzy